Foghorn Therapeutics Announces Board and Executive Changes
Ticker: FHTX · Form: 8-K · Filed: Dec 4, 2025 · CIK: 1822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | 8-K |
| Filed Date | Dec 4, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: FHTX
TL;DR
Foghorn Therapeutics (FHTX) board shakeup and exec comp changes filed today.
AI Summary
Foghorn Therapeutics Inc. announced on December 3, 2025, changes in its board of directors and executive compensation arrangements. Specifically, the company reported the departure of a director and the election of a new director, alongside updates to compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and compensation adjustments, which are typical for public companies and do not inherently indicate significant financial risk.
Key Numbers
- 001-39634 — SEC File Number (Identifier for Foghorn Therapeutics' SEC filings.)
- 1231 — Fiscal Year End (Indicates the end of Foghorn Therapeutics' fiscal year.)
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Registrant
- December 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Cambridge, MA (location) — Business address
FAQ
Who departed from the board of directors at Foghorn Therapeutics?
The filing indicates the departure of a director, but the specific name is not provided in this excerpt.
Was a new director elected to the board?
Yes, the filing states that a new director was elected.
What other item is reported in this 8-K filing?
The filing also reports on compensatory arrangements of certain officers.
What is the exact date of the earliest event reported?
The date of the earliest event reported is December 3, 2025.
In which state is Foghorn Therapeutics incorporated?
Foghorn Therapeutics Inc. is incorporated in Delaware.
Filing Stats: 604 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-12-04 07:00:22
Key Financial Figures
- $0.0001 — ge on which registered Common Stock, $0.0001 par value per share FHTX The Nasdaq Glo
Filing Documents
- fhtx-20251203.htm (8-K) — 29KB
- 0001628280-25-055215.txt ( ) — 145KB
- fhtx-20251203.xsd (EX-101.SCH) — 2KB
- fhtx-20251203_lab.xml (EX-101.LAB) — 22KB
- fhtx-20251203_pre.xml (EX-101.PRE) — 13KB
- fhtx-20251203_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FOGHORN THERAPEUTICS INC. By: /s/ Michael J. LaCascia Michael J. LaCascia Chief Legal Officer Date: December 4, 2025